Literature DB >> 8761240

Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy...

A R Winstock, L A King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8761240      PMCID： PMC2351818          DOI： 10.1136/bmj.313.7054.423b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Ecstasy and neurodegeneration.

Authors:  A R Green; G M Goodwin
Journal:  BMJ       Date:  1996-06-15

2.  Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.

Authors:  U D McCann; G A Ricaurte
Journal:  J Clin Psychopharmacol       Date:  1991-10       Impact factor: 3.153

3.  Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

Authors:  P K McGuire; H Cope; T A Fahy
Journal:  Br J Psychiatry       Date:  1994-09       Impact factor: 9.319

4.  The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.

Authors:  M I Colado; J L Williams; A R Green
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739
  4 in total
  1 in total

Review 1.  Management of self poisoning.

Authors:  A L Jones; G Volans
Journal:  BMJ       Date:  1999-11-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.